| Cover | Jan. 22, 2025 |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jan. 22, 2025 |
| Current Fiscal Year End Date | --12-31 |
| Entity File Number | 001-41245 |
| Entity Registrant Name | Conduit Pharmaceuticals Inc. |
| Entity Central Index Key | 0001896212 |
| Entity Tax Identification Number | 87-3272543 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 4851 Tamiami Trail North |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Naples |
| Entity Address, State or Province | FL |
| Entity Address, Postal Zip Code | 34103 |
| City Area Code | (646) |
| Local Phone Number | 491-9132 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, $0.0001 par value per share | |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | CDT |
| Security Exchange Name | NASDAQ |
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 | |
| Title of 12(b) Security | Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 |
| Trading Symbol | CDTTW |
| Security Exchange Name | NASDAQ |
